Stillwater Investment Management (Minnesota)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $3.12M | Buy |
76,391
+1,240
| +2% | +$53.6K | 0.84% | 28 |
|
|
2022
Q4 | $3.85M | Sell |
75,151
-215
| -0.3% | -$10.3K | 1.09% | 21 |
|
|
2022
Q3 | $3.3M | Buy |
75,366
+347
| +0.5% | +$16.9K | 1.02% | 21 |
|
|
2022
Q2 | $3.93M | Buy |
75,019
+524
| +0.7% | +$26.7K | 1.16% | 19 |
|
|
2022
Q1 | $3.86M | Buy |
74,495
+1,021
| +1% | +$53K | 0.97% | 23 |
|
|
2021
Q4 | $4.34M | Buy |
73,474
+418
| +0.6% | +$20.7K | 1.07% | 23 |
|
|
2021
Q3 | $3.14M | Sell |
73,056
-485
| -0.7% | -$21.5K | 0.84% | 32 |
|
|
2021
Q2 | $2.88M | Sell |
73,541
-174
| -0.2% | -$6.77K | 0.77% | 32 |
|
|
2021
Q1 | $2.67M | Buy |
73,715
+545
| +0.7% | +$19.4K | 0.77% | 35 |
|
|
2020
Q4 | $2.69M | Sell |
73,170
-4,474
| -6% | -$164K | 0.83% | 32 |
|
|
2020
Q3 | $2.7M | Buy |
77,644
+939
| +1% | +$32.9K | 0.98% | 27 |
|
|
2020
Q2 | $2.38M | Buy |
76,705
+1,455
| +2% | +$49.4K | 0.94% | 31 |
|
|
2020
Q1 | $2.33M | Sell |
75,250
-2,117
| -3% | -$72.1K | 1.11% | 24 |
|
|
2019
Q4 | $2.88M | Buy |
77,367
+2,642
| +4% | +$94.1K | 1.09% | 24 |
|
|
2019
Q3 | $2.55M | Buy |
74,725
+2,214
| +3% | +$80.5K | 1.06% | 25 |
|
|
2019
Q2 | $2.98M | Sell |
72,511
-1,608
| -2% | -$63.9K | 1.25% | 18 |
|
|
2019
Q1 | $2.99M | Sell |
74,119
-700
| -0.9% | -$28K | 1.22% | 19 |
|
|
2018
Q4 | $3.1M | Buy |
74,819
+148
| +0.2% | +$6.14K | 1.45% | 16 |
|
|
2018
Q3 | $3.12M | Sell |
74,671
-684
| -0.9% | -$26.3K | 1.26% | 19 |
|
|
2018
Q2 | $2.59M | Sell |
75,355
-553
| -0.7% | -$18.9K | 1.12% | 24 |
|
|
2018
Q1 | $2.56M | Buy |
75,908
+481
| +0.6% | +$16.5K | 1.12% | 23 |
|
|
2017
Q4 | $2.59M | Buy |
75,427
+1,057
| +1% | +$36K | 1.57% | 23 |
|
|
2017
Q3 | $2.52M | Buy |
74,370
+695
| +0.9% | +$22.3K | 1.15% | 21 |
|
|
2017
Q2 | $2.35M | Sell |
73,675
-1,564
| -2% | -$49.3K | 1.11% | 24 |
|
|
2017
Q1 | $2.44M | Buy |
75,239
+1,450
| +2% | +$45.7K | 1.17% | 20 |
|
|
2016
Q4 | $2.27M | Sell |
73,789
-388
| -0.5% | -$11.8K | 1.17% | 21 |
|
|
2016
Q3 | $2.38M | Buy |
74,177
+1,258
| +2% | +$42.1K | 1.29% | 18 |
|
|
2016
Q2 | $2.44M | Buy |
72,919
+1,571
| +2% | +$50.1K | 1.39% | 15 |
|
|
2016
Q1 | $2.01M | Buy |
71,348
+2,299
| +3% | +$65.7K | 1.19% | 27 |
|
|
2015
Q4 | $2.12M | Buy |
69,049
+2,102
| +3% | +$66.1K | 1.32% | 20 |
|
|
2015
Q3 | $2M | Sell |
66,947
-272
| -0.4% | -$8.72K | 1.34% | 20 |
|
|
2015
Q2 | $2.14M | Sell |
67,219
-200
| -0.3% | -$6.52K | 1.35% | 18 |
|
|
2015
Q1 | $2.23M | Buy |
67,419
+1,206
| +2% | +$38.3K | 1.43% | 15 |
|
|
2014
Q4 | $1.96M | Sell |
66,213
-924
| -1% | -$26.5K | 1.32% | 20 |
|
|
2014
Q3 | $1.88M | Buy |
67,137
+43
| +0.1% | +$1.21K | 1.33% | 19 |
|
|
2014
Q2 | $1.89M | Sell |
67,094
-1,023
| -2% | -$29.2K | 1.36% | 19 |
|
|
2014
Q1 | $2.08M | Sell |
68,117
-66
| -0.1% | -$1.97K | 1.58% | 15 |
|
|
2013
Q4 | $1.98M | Buy |
+68,183
| New | +$1.98M | 1.51% | 15 |
|
Other funds holding PFE
Stillwater Investment Management (Minnesota)'s PFE Position: Q1 2023 in Review
Stillwater Investment Management (Minnesota) increased its Pfizer (PFE) stake by 1.7% in Q1 2023, buying an estimated $53.6K and bringing the position to 76,391 shares worth $3.12M. The position accounts for 0.84% of the portfolio, ranked #28.
Stillwater Investment Management (Minnesota) first reported a position in PFE in Q4 2013 and has held it in 38 quarters since. The position peaked at $4.34M in Q4 2021. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Stillwater Investment Management (Minnesota) held 76,391 shares of Pfizer worth $3.12M as of Q1 2023.
- Stillwater Investment Management (Minnesota) bought 1,240 Pfizer shares in Q1 2023, an estimated $53.6K.
- Pfizer made up 0.84% of Stillwater Investment Management (Minnesota)'s portfolio in Q1 2023, its #28 holding.
- Stillwater Investment Management (Minnesota) first reported a position in Pfizer in Q4 2013 and has held it in 38 quarters since.
- Stillwater Investment Management (Minnesota)'s Pfizer position peaked at $4.34M in Q4 2021.
- 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Stillwater Investment Management (Minnesota)'s 13F filing for Q1 2023, filed 5 Apr 2023.